NCT05604794View on ClinicalTrials.gov

A Retrospective Effectiveness Trial of Ketamine-Assisted Psychotherapy in Adult Patients Coping With Mental Health

PHASE4CompletedINTERVENTIONAL
Enrollment

1,806

Participants

Timeline

Start Date

March 13, 2020

Primary Completion Date

June 16, 2022

Study Completion Date

June 16, 2022

Conditions
DepressionAnxietyPost Traumatic Stress Disorder
Interventions
COMBINATION_PRODUCT

Ketamine-Assisted Psychotherapy (KAP)

KAP consisting of 4-6 guided ketamine sessions with psychotherapy-only visits after dose 1 and 2 and then after every 2 subsequent doses.

Trial Locations (11)

10010

NYC Centre, New York

20005

Washington DC Centre, Washington D.C.

30316

Atlanta Centre, Atlanta

60654

Chicago Centre, Chicago

77027

Houston Centre, Houston

90404

LA Centre, Los Angeles

92037

San Diego Centre, San Diego

98109

Seattle Centre, Seattle

V6J 5B3

Vancouver Centre, Vancouver

E3B 7E6

Fredericton Centre, Fredericton

M5V 2C3

Field Trip Health, Toronto Centre, Toronto

All Listed Sponsors
lead

Field Trip Health

INDUSTRY

NCT05604794 - A Retrospective Effectiveness Trial of Ketamine-Assisted Psychotherapy in Adult Patients Coping With Mental Health | Biotech Hunter | Biotech Hunter